Latest News
Week ahead: US non-farm payrolls, BoE in the spotlight
All eyes over the coming week will be on the US non-farm payrolls report for July due out on Friday.
Weekly review
The FTSE 100 ended the week 147. 06 points higher, closing Friday’s session at 7,423. 43.
Director dealings: Rio Tinto CEO invests a day after disappointing results
Rio Tinto was at the top of the list of director buys on Friday, after its chief executive officer bought almost half a million pounds worth of shares.
London close: Stocks finish higher amid more earnings, data
London stocks were in the green at the close on Friday after another tsunami of corporate news, as well as a raft of inflation indicators in the US and a very large and positive surprise on second quarter euro area gross domestic product.
Agriterra gets $7.9m cash boost from major shareholder
Agricultural company Agriterra announced a “significant” injection of new funds from its major shareholder on Friday.
Parkmead launches farm-out process for Greater Perth Area
Parkmead has engaged corporate finance advisory firm Gneiss Energy to help find a suitable partner for its 100% interest in the Greater Perth Area development project, it announced on Friday.
University of Michigan July consumer confidence index little changed from preliminary reading
US consumer confidence was a tad stronger than expected last month, the results of a very closely-followed survey revealed.
Eneraqua describes 'encouraging' trading in year-to-date
Energy and water efficiency technology company Eneraqua said in an update that, after its initial public offering in November, trading in the first half of the financial year had been “encouraging” as it remained on course to deliver on its growth plans.
TruFin ups stake in Satago as it inks Lloyds Bank deal
TruFin said on Friday that its majority-owned investment Satago and Lloyds Banking Group have entered into a five-year commercial agreement for the bank to licence Satago's software platform for its single invoice finance and whole-of-book invoice factoring customers.
Chicago factory PMI falls by more than expected in July
Manufacturing sector activity in the Chicago area slowed more than expected in July, the results of a close-followed survey revealed.
Ovoca Bio enrols participants in women's sexual drug trial
Women’s health-focussed biopharmaceutical company Ovoca Bio announced the successful completion of participant enrollment in a phase 2 dose-ranging study assessing ‘orenetide’ on Friday.
Broker tips: Wizz Air, Kainos Group, AstraZeneca
Analysts at Berenberg lowered their target price on low-cost carrier Wizz Air from 3,300. 0p to 3,200. 0p on Friday, stating recent capacity rationalisation was aiding unit revenues for the summer.
US open: Stocks move higher on final trading day of July
Wall Street stocks traded higher at the bell on Friday as another busy week for corporate earnings gets set to draw to a close.
FTSE 100 movers: NatWest Group up against resistance, Intertek drags
NatWest Group raced to the top of the leaderboard at the end of the week with its shares bumping up against technical resistance around the 250. 0p mark after the lender beat analysts' estimates for its second quarter operating pre-tax proit and total income.
FTSE 250 movers: Vesuvius snaps higher, Aston Martin dips
Shares of engineered ceramics specialist Vesuvius topped the the FTSE 250 leaderboard on Friday, following a notifiicaction that fund manager GLG Partners had upped its stake in the outfit.
US personal incomes and spending rise more quickly than expected in June
US households continued to dip into their savings last month in order to finance their purchases amid continued price pressures.
US Q2 Employment Cost Index rises a bit more quickly than anticipated
A broad measure of workers' compensation increased modestly more quickly than anticipated over the three months to June.
Euro area Q2 GDP growth leaves economists' forecasts in the dust
Euro area second quarter gross domestic product growth left economists' forecasts in the dust.
Canaccord Genuity reiterates 'buy' rating on Kainos
Analysts at Canaccord Genuity reiterated their 'buy' rating and 1,350. 0p target price on software firm Kainos Group on Friday, stating "good things" come to those who wait.
ShoreCap stays at 'buy' on AstraZeneca, sees further upgrades ahead on product pipeline
Analysts at ShoreCap reiterated their 'buy' recommendation for shares of drugs giant AstraZeneca, describing its second quarter top-line growth of 37% year-on-year at constant exchange rates "impressive".